MoumitaBarua Canada

Dr. Moumita Barua is a Clinician Scientist and Assistant Professor in the Division of Nephrology at Toronto General Hospital and the Department of Medicine at the University of Toronto, respectively. The starting point of her research is to perform DNA sequencing in adults with glomerular and chronic kidney diseases. These genetic discoveries inform clinically relevant models to better define mechanisms. Ultimately Dr. Barua's goal is to translate research findings to clinical care for the improvement of diagnostics and outcomes in kidney disease.
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
Hands on Big Data Mining for the Nephrologist in 2024
HeatherAscani Chairperson ascanihk@med.umich.eduUnited States
KatherineTuttle Chairperson Katherine.Tuttle@providence.orgUniversity of Washington, Department of NephrologyUnited States
MatthiasKretzler Chairperson kretzler@umich.eduUniversity of MichiganUnited States
  • Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse
    VijiNair Speaker vijin@med.umich.eduUniversity of MichiganUnited States
  • Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI
    MatthiasKretzler Speaker kretzler@umich.eduUniversity of MichiganUnited States
  • The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany
  • Panel Discussion
Hall C1
APOL1 Targeted Therapies: Who to Test and Which Disease to Treat?
Fatiu AbiolaArogundade Chairperson fatiu3@yahoo.comObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria Nigeria
FernandaSales Luiz Vianna Chairperson fslvianna@gmail.comUniversidade Federal do Rio Grande do SulBrazil
OpeyemiOlabisi Chairperson opeyemi.olabisi@duke.eduDuke University School of MedicineUnited States
  • Ethical Aspects of Race-based Genetic Testing
    AnaIltis Speaker iltisas@wfu.eduWake Forest UniversityUnited States
  • Contribution of ApoL1 Risk Genotype to HIVAN
    SaraladeviNaicker Speaker Saraladevi.Naicker@wits.ac.zaUniversity of the Witwatersrand South Africa
  • Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa
    DwomoaAdu Speaker dwoms@blueyonder.co.ukUniversity of Ghana Medical SchoolGhana
  • Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials
    OgoEgbuna Speaker ogo_egbuna@vrtx.comVertex Pharmaceuticals IncUnited States
  • Q and A
Hall C2
Precise Phenotyping and Treatment
HeatherReich Chairperson Heather.Reich@uhn.caUniversity of Toronto, University Health NetworkCanada
SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comSanatorio Parque SAArgentina
  • Deciphering the IGAN Cell Atlas
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany
  • Complement-mediated Kidney Diseases in the Era of Complement Inhibitors
    MarinaVivarelli Speaker marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly
  • CART-T Cell for Refractory Lupus
    JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio
  • New Targets to Reduce the Burden of Rare Kidney Diseases
    LauraMariani Speaker lmariani@umich.eduUniversity of MichiganUnited States
  • Q and A
Hall C4
3 p.m.
4 p.m.
New Tools to Study Kidney Disease
RafaelMaldonado Chairperson ramaldonado@gmail.comArgentina
ReikoInagi Chairperson inagi-r@m.u-tokyo.ac.jpThe University of Tokyo Graduate School of MedicineJapan
  • Understanding Glomerular Damage: From Spatial Transcriptomics to Chip Technology
    LauraPerin Speaker LPerin@chla.usc.eduUnited States
  • Spatial Metabolomics of Kidney Disease
    TonRabelink Speaker a.j.rabelink@lumc.nlLUMCNetherlands
  • Constructing an Epigenetic Network for Diabetic Nephropathy
    Sam El-Osta Speaker sam.el-osta@baker.edu.auBaker Heart and Diabetes InstituteAustralia
  • Q and A
Hall E

Day 2 - Monday April 15, 2024

Time Session
12:15 p.m.
1:15 p.m.
Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD?
MartaAdragna Chairperson marta.adragna@gmail.comArgentina
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
  • Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? - All Patients
    AlbertienVan Eerde Speaker vanEerde@umcutrecht.nlDepartment of Genetics, UMC Utrecht, The NetherlandsNetherlands
  • Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? High-risk Populations Only
    HilaMilo Rasouly Speaker Hila.MiloRasouly@columbia.eduColumbia UniversityUnited States
Hall A
4:30 p.m.
5:30 p.m.
Designing Smart Clinical Trials
DebbieGipson Chairperson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States
JonathanBarratt Chairperson jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
  • Patients Subphenotyping: The Example of Diabetic Kidney Disease
    John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States
  • Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
    LauraMariani Speaker lmariani@umich.eduUniversity of MichiganUnited States
  • Targeted Approaches in Clinical Trial Design
    HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
  • Q and A
Hall D

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10:30 a.m.
Clinical Management of Glomerulonephritis (GN)
Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico
ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina
  • Updates on IgAN Management
    HernánTrimarchi Speaker htrimarchi@hotmail.comHOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
  • Membranous GN Classification and Management
    PierreRonco Speaker pierreronco@yahoo.frHôpital TenonFrance
  • MPGN Updates
    SanjeevSethi Speaker sethi.sanjeev@mayo.eduMayo ClinicUnited States
  • Managing Vasculitis
    RobertaFenoglio Speaker roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly
  • Q and A
Hall A
12:30 p.m.
1:30 p.m.
New Insights into C3 Glomerulonephritis: Focus on Pathogenesis and Potential Therapeutic Targets
AnujaJava Chairperson ajava@wustl.eduWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUISUnited States
Prof LizLightstone Chairperson l.lightstone@imperial.ac.ukImperial College LondonUnited Kingdom
  • Complement in Kidney Disease: Overview of the Complement Cascade in Kidney Injury
    Peter Zipfel Speaker Peter.Zipfel@hki-jena.deLeibniz Institute for Natural Product Research and Infection BiologyGermany
  • C3 Glomerulopathy: New Developments and Therapeutic Targets
    CarlaNester Speaker carla-nester@uiowa.eduUniversity of IowaUnited States
  • Challenges in Diagnosing C3G
    SallyJohnson Speaker sallyajohnson73@gmail.comNational Renal Complement Therapeutics Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, United KingdomUnited Kingdom
  • Q and A
Hall C1
Rare and Orphan Diseases
AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States
RobertaFenoglio Chairperson roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly
VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina
  • Alport Spectrum Disorders (Genetics)
    MoumitaBarua Speaker moumita.barua@uhn.caCanada
  • Genetics of Nephrotic Syndrome
    SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduColumbia UniversityUnited States
  • Lupus Nephritis Transcriptomics Across Time and Space
    AnaMalvar Speaker avmperrin@yahoo.com.arHospotal Fernandez, Organizacion Medica de InvestigacionArgentina
  • Q and A
Hall E

Pre-Congress - Saturday April 13, 2024

Time Session
9 a.m.
11 a.m.
Annual Review of Nephrology Course: A Review of Key Topics in Nephrology
MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina
MitchellRosner Chairperson MHR9R@hscmail.mcc.virginia.eduUniveristy of Virginia HealthUnited States
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • Changing Paradigms in the Care of Acute Kidney Injury
    MarliesOstermann Speaker Marlies.Ostermann@gstt.nhs.ukKing's College LondonUnited Kingdom
  • Update on Electrolyte Disorders
    MitchellRosner Speaker MHR9R@hscmail.mcc.virginia.eduUniveristy of Virginia HealthUnited States
  • How to Incorporate Genetic Testing in Nephrology
    MoumitaBarua Speaker moumita.barua@uhn.caCanada
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina
  • Q and A
Hall C4
11:30 a.m.
1:30 p.m.
Annual Review of Nephrology Course: Treatment Updates for Kidney Diseases
MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina
MitchellRosner Chairperson MHR9R@hscmail.mcc.virginia.eduUniveristy of Virginia HealthUnited States
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • Changing Paradigms in the Care of Chronic Kidney Disease: Slowing Progression
    Magdalena Madero Speaker madero.magdalena@gmail.comChief of Nephrology, Instituto Nacional de CardiolMexico
  • What’s New in Dialysis Therapies
    ThiagoDe Azevedo Reis Speaker thiagoreisnefro@gmail.comHospital Sírio-Libanês, São Paulo, Brazil & Fenix Brazil
  • Therapeutic Approaches for Polycystic Kidney Disease
    Roman-UlrichMueller Speaker roman-ulrich.mueller@uk-koeln.deUniversity of CologneGermany
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina
  • Q and A
Hall C4
2:15 p.m.
4:15 p.m.
Annual Review of Nephrology Course: Glomerular Diseases, Transplantation and Hypertension: What’s New?
MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina
MitchellRosner Chairperson MHR9R@hscmail.mcc.virginia.eduUniveristy of Virginia HealthUnited States
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • Glomerular Diseases: Update
    YelenaDrexler Speaker yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • Transplantation 2023 and Beyond
    ShrutiTapiawala Speaker shruti16374@gmail.comGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, MumbaiIndia
  • Hypertension and the Kidney
    GeorgeThomas Speaker thomasg3@ccf.orgASNUnited States
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina
  • Q and A
Hall C4